KRRO-110
Live / Registered — Registered (as of 24 Feb 2026)
What this means for you
Registered since 24 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98365999
- Registration number
- 8152849
- Mark type
- Stylized text
- Filed
- 19 Jan 2024
- Published for opposition
- 17 Sept 2024
- Registered
- 24 Feb 2026
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Oligonucleotide preparations for the treatment of genetic diseases
Owner
- Korro Bio, Inc., Cambridge, MA, US
- Korro Bio, Inc., Cambridge, MA, US
- Korro Bio, Inc., Cambridge, MA, US
Prosecution history
- 24 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 04 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 04 Feb 2026 — SU-EXAMINER'S AMENDMENT WRITTEN
- 09 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN
- 30 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Mar 2025 — USE AMENDMENT FILED